Evidence map›Paper›PMID 39108637›Full record

ArticleNAR genomics and bioinformatics2024

BioFlow-Insight: facilitating reuse of Nextflow workflows with structure reconstruction and visualization.

George Marchment, Bryan Brancotte, Marie Schmit, Frédéric Lemoine, Sarah Cohen-Boulakia

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

George MarchmentUniversité Paris-Saclay, CNRS, Laboratoire Interdisciplinaire des Sciences du Numérique, 91405, Orsay, France.ORCID https://orcid.org/0000-0002-4565-3940
Bryan BrancotteInstitut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France.ORCID https://orcid.org/0000-0001-8669-5525
Marie SchmitInstitut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France.ORCID https://orcid.org/0009-0007-8119-1222
Frédéric LemoineInstitut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub, Paris, France.ORCID https://orcid.org/0000-0001-9576-4449
Sarah Cohen-BoulakiaUniversité Paris-Saclay, CNRS, Laboratoire Interdisciplinaire des Sciences du Numérique, 91405, Orsay, France.ORCID https://orcid.org/0000-0002-7439-1441

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioinformatics workflows are increasingly used for sharing analyses, serving as a cornerstone for enhancing the reproducibility and shareability of bioinformatics analyses. In particular, Nextflow is a commonly used workflow system, permitting the creation of large workflows while offering substantial flexibility. An increasing number of Nextflow workflows are being shared on repositories such as GitHub. However, this tremendous opportunity to reuse existing code remains largely underutilized. In cause, the increasing complexity of workflows constitute a major obstacle to code reuse. Consequently, there is a rising need for tools that can help bioinformaticians extract valuable information from their own and others' workflows. To facilitate workflow inspection and reuse, we developed BioFlow-Insight to automatically analyze the code of Nextflow workflows and generate useful information, particularly in the form of visual graphs depicting the workflow's structure and representing its individual analysis steps. BioFlow-Insight is an open-source tool, available as both a command-line interface and a web service. It is accessible at https://pypi.org/project/bioflow-insight/ and https://bioflow-insight.pasteur.cloud/.

Identifiers

PMID39108637
PMCPMC11302447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.